Stock Groups

Is Autolus Therapeutics Setting Up for a Big Move? By StockNews

by Mike Robinson

[ad_1]

© Reuters. Autolus Therapeutics Set for Big Move

In the chart, a triangle-shaped symmetrical pattern is formed. Autolus Therapeutics PLC (NASDAQ): Stocks are expected to move through their resistance lines or reach the support levels. You can read more on how to prepare yourself for a possible breakout or breakup. Five programs are included in the company’s early-stage clinical pipeline: AUTO1, AUTO1/22, Auto3, AUTO4, and AUTO6.

A new partnership was announced by the company. Moderna (NASDAQ:), in which MRNA could use some of AUTL’s proprietary binders in new cancer therapies. AUTL recently reported that AUTO1, an experimental CD19-cell therapy for non-Hodgkin lymphoma patients, achieved 100% remission during an early stage study.

At the end of the latest quarter, cash was at $216million, while long-term debt was only $19million. The average annual growth in sales over the last three year has been 31.8%. Sales are forecast to decline 16.7% in the current quarter, despite an average growth of 31.8% per year.

Continue reading on StockNews

Disclaimer Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion MediaFusion Media and anyone associated with it will not assume any responsibility for losses or damages arising from the use of this information. This includes data including charts and buy/sell signal signals. Trading the financial markets is one of most risky investment options. Please make sure you are fully aware about the costs and risks involved.



[ad_2]